Surveillance has surged for favorable-risk prostate cancer, but focal therapy remains in use despite limited evidence and ...

Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery ...

Prostate cancer is often resistant to immunotherapy, which harnesses a person's immune system to recognize and destroy tumors. But a new technology that targets RNA in cancer cells gave immunotherapy ...

Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...

Three decades after UC San Francisco pioneered "active surveillance" for patients with low-risk prostate cancer, a new study has found that the vast majority of veterans with the diagnosis pursued ...

Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical textbooks present as relatively binary: remove the entire prostate gland or ...

Proton beam therapy continues to generate significant interest — and controversy — in prostate cancer. About 45 cancer centers in the US offer proton therapy to treat a variety of cancers, including ...